Archimed, a pan-European private equity healthcare specialist, made a €70m bid for Bomi Italia, a medtech and pharma services provider. The bid for Bomi Group, listed on Borsa Italia’s AIM market translates into a per share offer of €4.00 (30.67% above last official closing price of €3.06 and 50.38% above the six-month average price of €2.66). “In addition to its sector expertise and industry networks, ArchiMed intends to make significant investments, allowing Bomi Group to expand more rapidly, both organically and through acquisitions. The entry of such a strong and specialized stakeholder represents clear added value when it comes to the fulfilment of our ambitious growth targets,” says Bomi Group Chief Executive Marco Ruini.